Advertisement

The Scientist

» genome and immunology

Most Recent

image: Skin Microbes Alter Immunity

Skin Microbes Alter Immunity

By | July 30, 2012

Like commensal gut organisms, skin microbiota appear to help the mammalian immune system mature and stay regulated.

0 Comments

image: Frankenlympics?

Frankenlympics?

By | July 26, 2012

Allowing athletes to enhance their performance by using genetic engineering to manipulate their DNA may become a reality of future Olympic Games.

2 Comments

image: Double Duplication

Double Duplication

By | July 24, 2012

Two whole genome duplications boosted the complexity of the ancestor of all vertebrates, but also introduced potential for disease.

0 Comments

image: Genome Digest

Genome Digest

By | July 11, 2012

What researchers are learning as they sequence, map, and decode species’ genomes

0 Comments

image: Filling in the Missing Letters

Filling in the Missing Letters

By | July 3, 2012

A new algorithm brings together data from second - and third - generation genome sequencers.

1 Comment

image: Ubiquitin Chains in Action

Ubiquitin Chains in Action

By | July 1, 2012

Present in every tissue of the body, ubiquitin appears to be involved in a dizzying array of functions, from cell cycle and division to organelle and ribosome biogenesis, as well as the response to viral infection. The protein plays at least two role

0 Comments

image: Genome Digest

Genome Digest

By | June 28, 2012

What researchers are learning as they sequence, map, and decode species’ genomes

0 Comments

image: The Fungus Among Us

The Fungus Among Us

By | June 11, 2012

Researchers find a slew of new fungal species inhabiting the human gut, and suggest a link to an inflammatory bowel disease.

1 Comment

image: Fetal Genome in Mom's Blood

Fetal Genome in Mom's Blood

By | June 7, 2012

Scientists have sequenced the genome of an 18.5 week-old fetus using blood and saliva samples taken from the parents.

0 Comments

image: Parkinson's Vax Enters Clinical Trials

Parkinson's Vax Enters Clinical Trials

By | June 7, 2012

Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies